ImmunAdd Inc. to Showcase Next-Generation Saponin Adjuvants at 2025 BIO International Convention in Boston

On June 13, 2025 ImmunAdd Inc., a Taiwan-based biotech company, reported its participation in the 2025 BIO International Convention, taking place June 16–19 at the Boston Convention and Exhibition Center (Press release, ImmunAdd, JUN 13, 2025, View Source [SID1234653876]). The company will present its latest advancements in synthetic vaccine adjuvants and immune modulation technologies to the global biotech community.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

At this year’s convention, ImmunAdd will spotlight its proprietary fully synthetic saponin adjuvant IA-05, alongside its IAS-01 adjuvant system, which combines IA-05 with a Toll-like receptor (TLR) agonist. The IAS-01 platform simultaneously activates both humoral and cellular immune responses, offering enhanced protection and longer-lasting durability for vaccine applications.

"Our participation in the BIO Convention marks an important milestone in our international outreach," said by Dr. Pi-Hui Liang, the CEO of ImmunAdd. "As one of the most influential biotech gatherings in the world, this event offers us a valuable opportunity to share our innovation roadmap and engage with potential global partners and investors."

The convention will also serve as a strategic platform for ImmunAdd to explore international collaborations and commercial partnerships. The company plans to engage with vaccine developers, biopharmaceutical companies, and research institutions to discuss opportunities in co-development, licensing, and investment.

ImmunAdd warmly invites industry partners to visit its booth to learn more about how its patented adjuvant technology is driving the future of vaccines and immunotherapies.

Exhibition Details:
BIO International Convention 2025
Location: Boston Convention and Exhibition Center, Boston, MA, USA
Dates: June 16–19, 2025
Booth: Taiwan Pavilion